Free Trial

Revolve Wealth Partners LLC Purchases Shares of 933 Veeva Systems Inc. (NYSE:VEEV)

Veeva Systems logo with Medical background

Revolve Wealth Partners LLC purchased a new stake in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 933 shares of the technology company's stock, valued at approximately $216,000.

A number of other institutional investors have also bought and sold shares of VEEV. Wedmont Private Capital boosted its position in shares of Veeva Systems by 4.1% during the 1st quarter. Wedmont Private Capital now owns 2,200 shares of the technology company's stock worth $480,000 after purchasing an additional 87 shares in the last quarter. Clean Yield Group boosted its position in shares of Veeva Systems by 32.8% during the 1st quarter. Clean Yield Group now owns 22,020 shares of the technology company's stock worth $5,100,000 after purchasing an additional 5,433 shares in the last quarter. Sivia Capital Partners LLC bought a new position in shares of Veeva Systems during the 1st quarter worth about $222,000. Gateway Investment Advisers LLC boosted its position in shares of Veeva Systems by 6.7% during the 1st quarter. Gateway Investment Advisers LLC now owns 39,362 shares of the technology company's stock worth $9,117,000 after purchasing an additional 2,472 shares in the last quarter. Finally, Blue Zone Wealth Advisors LLC boosted its position in shares of Veeva Systems by 9.7% during the 1st quarter. Blue Zone Wealth Advisors LLC now owns 17,219 shares of the technology company's stock worth $3,988,000 after purchasing an additional 1,525 shares in the last quarter. Institutional investors own 88.20% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on VEEV shares. Needham & Company LLC increased their price objective on shares of Veeva Systems from $270.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Wells Fargo & Company upped their target price on shares of Veeva Systems from $285.00 to $300.00 and gave the stock an "overweight" rating in a report on Thursday, May 29th. Stephens restated an "overweight" rating and issued a $280.00 target price on shares of Veeva Systems in a report on Thursday, March 6th. Robert W. Baird upped their target price on shares of Veeva Systems from $283.00 to $285.00 and gave the stock an "outperform" rating in a report on Thursday, March 6th. Finally, Raymond James upped their target price on shares of Veeva Systems from $285.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 29th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $269.80.

View Our Latest Analysis on VEEV

Insider Transactions at Veeva Systems

In related news, SVP Jonathan Faddis sold 787 shares of the firm's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $226.20, for a total value of $178,019.40. Following the completion of the transaction, the senior vice president now directly owns 8,668 shares of the company's stock, valued at approximately $1,960,701.60. This trade represents a 8.32% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Thomas D. Schwenger sold 1,200 shares of the firm's stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $220.97, for a total transaction of $265,164.00. Following the completion of the transaction, the insider now directly owns 25,889 shares of the company's stock, valued at approximately $5,720,692.33. This trade represents a 4.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,869 shares of company stock worth $1,284,917 in the last quarter. Insiders own 10.30% of the company's stock.

Veeva Systems Stock Down 1.7%

Shares of VEEV stock opened at $285.08 on Monday. The company has a 50 day moving average of $235.57 and a 200-day moving average of $230.33. Veeva Systems Inc. has a 12-month low of $176.41 and a 12-month high of $291.68. The firm has a market cap of $46.38 billion, a P/E ratio of 70.39, a PEG ratio of 1.89 and a beta of 0.99.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The technology company reported $1.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.23. Veeva Systems had a net margin of 25.07% and a return on equity of 13.56%. The company had revenue of $759.04 million during the quarter, compared to analyst estimates of $728.38 million. During the same quarter last year, the business posted $1.50 EPS. Veeva Systems's quarterly revenue was up 16.7% compared to the same quarter last year. As a group, equities analysts expect that Veeva Systems Inc. will post 4.35 EPS for the current year.

Veeva Systems Company Profile

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Read More

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines